Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Endocrinol ; 135(1): 77-83, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1431686

ABSTRACT

A homologous radioimmunoassay for the measurement of epidermal growth factor (EGF) levels in pig tissues and body fluids has been developed using an antiserum to recombinant porcine EGF. The assay is highly specific, showing no cross-reactivity with a variety of other polypeptides including the structurally related protein, transforming growth factor-alpha. Furthermore, < 1% cross-reactivity was observed with mouse EGF emphasizing the necessity for homologous assays for EGF measurement. Immunoreactive EGF was present in extracts of pig kidney and pancreas (3.44 +/- 0.43 and 0.76 +/- 0.13 (S.E.M.) pmol/g wet weight respectively), but was not detected in extracts of submaxillary gland or liver. Although immunoreactive EGF was not detectable in uterine, allantoic or ovarian follicular fluids, colostrum contained EGF at biologically active concentrations (0.84 +/- 0.15 nmol/l). Immunoreactive EGF was also present in pig urine, with similar concentrations in samples from male or female animals. In addition, pig urine inhibited the binding of 125I-labelled EGF to 3T3 fibroblasts and stimulated DNA synthesis in quiescent monolayers of these cells, indicating that the immunoreactive material in urine is biologically active. Quantitative comparisons of the data presented here with that published previously indicate considerable species variation in the EGF levels of various tissues and body fluids.


Subject(s)
Body Fluids/chemistry , Epidermal Growth Factor/analysis , Kidney/chemistry , Pancreas/chemistry , Swine/metabolism , Animals , Colostrum/chemistry , Epidermal Growth Factor/urine , Female , Male , Pregnancy , Radioimmunoassay
2.
Biochem J ; 270(2): 557-60, 1990 Sep 01.
Article in English | MEDLINE | ID: mdl-2169245

ABSTRACT

In Swiss 3T3 cells, depletion of protein kinase C (PKC) by prolonged incubation with phorbol esters potentiates the formation of total inositol phosphates in response to bombesin or vasopressin [Blakeley, Corps & Brown (1989) Biochem. J. 258, 177-185]. The characteristics of the accumulation of inositol phosphates in control and PKC-depleted cells stimulated by bombesin, vasopressin or prostaglandin F2 alpha (PGF2 alpha) have now been compared. The potentiation of the PGF2 alpha response was greater than that of the vasopressin response which was, in turn, greater than that of the bombesin response. The time courses of the responses to all three agonists were biphasic, and both phases of the response were amplified in the PKC-depleted cells. These results provide further evidence for the involvement of a PKC-mediated negative-feedback loop regulating phosphoinositide hydrolysis in response to several 3T3 cell mitogens. The differential potentiation of the response to these agonists suggests that PKC might act at multiple sites within the signal transduction pathway.


Subject(s)
Mitogens/pharmacology , Phosphatidylinositols/metabolism , Protein Kinase C/metabolism , Animals , Bombesin/pharmacology , Cell Line , Dinoprost/pharmacology , Drug Synergism , Hydrolysis , Kinetics , Mice , Signal Transduction , Tetradecanoylphorbol Acetate/pharmacology , Vasopressins/pharmacology
3.
Development ; 110(1): 221-7, 1990 Sep.
Article in English | MEDLINE | ID: mdl-1706979

ABSTRACT

125I-labelled epidermal growth factor (125I-EGF) and 125I-labelled insulin-like growth factor-I (125I-IGF-I) bound to trophoderm cells from pig blastocysts obtained on days 15-19 of pregnancy. Specific binding was detected on freshly isolated cell suspensions and on cells cultured for several days. The binding of 125I-EGF was inhibited by increasing concentrations of EGF, but not by various other growth factors and hormones. Chemical cross-linking of 125I-EGF to its receptors using disuccinimidyl suberate (DSS) revealed a radiolabelled band of relative molecular mass 160,000, similar to that identified as the EGF receptor in other cell types. The binding of 125I-IGF-I was inhibited by both IGF-I and insulin, indicating that the receptors were either type I IGF receptors or insulin receptors. Cross-linking of 125I-IGF-I to serum-free supernatants from trophoderm cultures showed that the cells secreted an IGF-binding protein, giving a complex of relative molecular mass about 45,000. The presence of receptors for EGF and IGF/insulin suggests that these factors could be involved in regulating the growth and development of the early blastocyst.


Subject(s)
Blastoderm/metabolism , ErbB Receptors/metabolism , Insulin-Like Growth Factor I/metabolism , Receptors, Cell Surface/metabolism , Swine/embryology , Animals , Carrier Proteins/biosynthesis , Carrier Proteins/metabolism , Cells, Cultured , Insulin-Like Growth Factor Binding Proteins , Receptors, Somatomedin , Swine/metabolism
4.
Biochem J ; 263(3): 977-80, 1989 Nov 01.
Article in English | MEDLINE | ID: mdl-2557015

ABSTRACT

The vasoactive peptide endothelin is shown to be a potent mitogen for Swiss 3T3 cells. Although endothelin has little effect on DNA synthesis when added alone to cells in serum-free medium, the peptide synergizes very strongly with several other growth factors. A half-maximal response to endothelin is observed at approx. 0.3 nM, with a maximal effect at 3 nM. Over the same concentration range, endothelin stimulates a 2-fold increase in the accumulation of cellular inositol phosphates. Endothelin may prove to be a useful additional agonist for studying the signalling pathways involved in the control of 3T3-cell proliferation.


Subject(s)
Cell Cycle/drug effects , DNA/biosynthesis , Growth Substances/pharmacology , Peptides/administration & dosage , Animals , Binding, Competitive , Bombesin/pharmacology , Drug Synergism , Endothelins , Epidermal Growth Factor/pharmacology , ErbB Receptors/metabolism , Fibroblast Growth Factors/pharmacology , Inositol Phosphates/metabolism , Insulin/pharmacology , Mice , Peptides/metabolism , Phosphatidylinositols/metabolism , Platelet-Derived Growth Factor/pharmacology , Transforming Growth Factors/pharmacology
5.
Biochem J ; 252(1): 227-35, 1988 May 15.
Article in English | MEDLINE | ID: mdl-2844145

ABSTRACT

Bombesin and bombesin-related peptides such as gastrin-releasing peptide (GRP) stimulate DNA synthesis and proliferation of Swiss 3T3 cells in culture. We have used 125I-labelled [Tyr4]bombesin and 125I-labelled GRP to characterize and identify the receptors for these peptides on Swiss 3T3 cells. The binding of 125I-[Tyr4]bombesin, which retained full biological activity, was maximal between 20 and 30 min incubation at 37 degrees C, after which continued incubation led to a decline in cell-associated radioactivity. This decline was markedly slowed by the presence of lysosomal enzyme inhibitors. Specificity of the binding site was indicated by the competitive inhibition of binding by bombesin-related peptides, but not by unrelated peptides and growth factors. Scatchard analysis of binding data indicated a single class of high-affinity receptors. The calculated value for the dissociation constant (Kd) was 2.1 nM and each cell possesses approx. 240,000 receptors. Because [Tyr4]bombesin has no free amino group, 125I-GRP was used in chemical cross-linking studies. When disuccinimidyl suberate was used to covalently couple 125I-GRP to the cells, two major radiolabelled complexes were detected with molecular masses of approx. 80,000-85,000 and 140,000. The binding of 125I-[Tyr4]bombesin to the cells was pH-dependent with maximal binding at pH 6.5-7.5 and effectively no specific binding at pH values below 4.5. At 37 degrees C, cell-associated 125I-[Tyr4]bombesin quickly became resistant to removal by acidic buffers, suggesting its rapid transfer to an intracellular compartment. However, pre-incubation with unlabelled [Tyr4]bombesin did not induce down-regulation of bombesin receptors as measured by the subsequent binding of 125I-[Tyr4]bombesin. In contrast with the Swiss 3T3 cells, specific binding of 125I-[Tyr4]bombesin was not detectable in two cell lines which are biologically unresponsive to bombesin-related peptides.


Subject(s)
Bombesin/metabolism , Receptors, Neurotransmitter/metabolism , Cell Line , Cross-Linking Reagents , Electrophoresis, Polyacrylamide Gel , Gastrin-Releasing Peptide , Hydrogen-Ion Concentration , Iodine Radioisotopes , Ligands , Peptides/metabolism , Receptors, Bombesin , Succinimides
SELECTION OF CITATIONS
SEARCH DETAIL
...